Clinical trial
MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With…
NCT00401492 · National Cancer Institute, Naples, Other · Completed
Key facts
| NCT number | NCT00401492 |
|---|---|
| Title | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer |
| Official title | Phase II Study of Chemotherapy With Gemcitabine in Prolonged Infusion or With Schedules With Cisplatin in Non-small Cell Lung Cancer Elderly Patients |
| Lead sponsor | National Cancer Institute, Naples, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine prolonged continuous infusion, cisplatin, vinorelbine |
| Enrollment | 159 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Nov 20, 2006 |
| Last update posted | Jul 13, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: